美国心脏移植过渡桥梁心脏辅助系统VentrAssist研究

作者:ABoyle，NMoazami   日期:2009/4/30 0:00:00

国际循环网版权所有，谢绝任何形式转载，侵犯版权者必予法律追究。

Conclusions:VentrAssist LVAD exceeded performance goal at pre-specified interim analysis.Survival at 180 days 85%.Statistically & clinically significant improvement in QOL & functional status over time (duration of support)